Monday 19 October - Tuesday 20 October 2020, Zoom

Chairs

Francisco Müssnich

Barbosa Müssnich Aragão, Rio de Janeiro and São Paulo

Francisco Müssnich, or Chico, as he likes to be called, is one of BMA’s partners. He has unparalleled experience in a wide range of corporate matters and in highly complex M&A and cross border transactions.

He acts in both national and international arbitrations, and provides strategic advice in hostile takeovers and corporate disputes. He has represented clients, all leaders in their sectors, in historic transactions in Brazil over the last two decades.

In 2014, Chico was named one of the 15 most powerful lawyers in Brazil.

Monique Mavignier

Barbosa Müssnich Aragão, Rio de Janeiro and São Paulo

Monique Mavignier is a partner in BMA’s corporate practice with a solid track record on both the sell and buy sides of private and public M&A transactions, divestitures, financial matters, private equity investments, and corporate, governance and securities law matters. She has extensive experience representing national and international companies doing business across a broad range of industries such as beverage/food, retail, energy, communications and construction.

Paola Lozano

Skadden, Arps, Slate, Meagher & Flom, New York

Co-chair of Skadden’s Latin America group, head of its Spanish language corporate practice and former member of Skadden’s policy committee.

As a New York-based M&A partner, she leads mergers, acquisitions, dispositions, private equity and other corporate matters for Fortune 500 companies, multilatinas, private equity funds and investment banks. Examples include:

Citigroup’s sale of its consumer banking and credit card businesses to: Banco Santander in Argentina; Itaú in Brazil; Scotiabank in Panama and Costa Rica; Promerica in Guatemala; Banco Ficohsa in Honduras and Nicaragua; Terra Group in El Salvador; and Colpatria and Bank of Nova Scotia in Colombia; its sale of Citigroup Global Services Limited to Tata Consultancy Services Limited (India), and a related bpo services agreement for $2.5 billion

Paul Schnell

Skadden, Arps, Slate, Meagher & Flom, New York

Mr. Schnell is recognized as a U.S. legal "legend" for being in top 500 lawyers in U.S. in each of last 10 years (Lawdragon). Recognized in both U.S. and Latin America as a leading lawyer in areas such as M&A (highest Band 1 ranking in Chambers for each of U.S., Latin America and Brazil), private equity, governance, corporate, finance and health care. Surveys recognizing Mr. Schnell include Chambers Global, Chambers USA, Chambers Latin America, U.S. News and World Report, Financial Times, Best Lawyers in America, Who's Who Legal, Lawdragon 500 Leading Lawyers in America, and IFLR1000. Co-chairs firm's Latin America practice.

Keynote Speaker

Arminio Fraga

Founder, Co-CIO Hedge Funds and Private Equity, Gávea Investimentos, São Paulo

Founder of Gávea Investimentos and the Institute for Health Policy Studies (IEPS). Member of the Group of Thirty and the Council on Foreign Relations. President of the Central Bank of Brazil (1999-2002), Chairman of B3, Managing Direction of Soros Fund Management. BA from PUC-Rio and PhD from Princeton University, where he served as a Trustee. Taught at PUC-Rio, EPGE-FGV, SIPA-Columbia and the Wharton School.

Speakers

Mariano Luchetti

Bruchou, Fernández Madero & Lombardi, Buenos Aires

Max Ritter

Managing Director, Goldman Sachs, New York

Patricia Moraes

Founding Partner, Unbox Capital, São Paulo

Patricio Trad Cepeda

Mijares, Angoitia, Cortés y Fuentes, Mexico City

Flávia Mouta Fernandes

B3, São Paulo

Vanessa Dager

Managing Director, Credit Suisse, New York

Programme

Monday 19th October
All times are São Paulo, Brazil time (UTC – 3)

9.30: Chairs’ welcome

9.45: The bankers' and industry view – an M&A forecast 

To kick off the conference and set the scene, leaders in banking and industry will survey opportunities and challenges in Latin American M&A deal-making. 

Leading bankers and industry representatives will offer their insights on the continuing impact of COVID-19 on deal-making and how to address the business and financial hurdles posed by the pandemic. Prospects for 2020 Q4 and for 2021 will be discussed, including where to expect more or less activity; in different countries and industries, for different types of deals, and for different M&A parties, including strategic, PE and minority investors, and financially strong and troubled companies.

10.35: Keynote and Q&A

10.55: Hostile activism in 2020 – the debt view, the equity view
Have the effects of the pandemic in the markets opened up space for more activism and opportunistic moves? Are hostile takeovers now presented in different ways? What are the tools available to shareholders and management to deal with minority requests and unsolicited offers? And looking to the bright side, would there be an opportunity to increase governance in this scenario? 

11.45: Close of day one

 

Tuesday 20th October

9.30: Chairs’ welcome

9.45: How the different classes of shares are affecting transactions, corporate and capital structures, and risk of migration to different jurisdictions

Leading M&A practitioners discuss the migration of companies to foreign jurisdictions that are more friendly towards controllers, allowing the implementation of their idiosyncratic vision of the business whilst retaining control. The panel will discuss the perils of tiny controllers in dual-class companies who may have an incentive to carry on related party transactions that are detrimental to the corporation. We will also visit the regulations and remedies available to prevent this behaviour.

10.35: Fireside chat and Q&A

10.55: Deal-making in COVID-19 times and beyond

The panel will explore the most significant challenges M&A transactions have experienced as a result of the worldwide crisis, the measures available to address such challenges, and the opportunities created in the aftermath.  The panelists will also discuss M&A as a tool to manage and enhance corporate value while surviving the crisis.  

11.45: Close of day two

Ticket Prices

Private practice rate
Type Price
Standard $10

 

In-house/government rate
Type Price
Standard $0